Related Experiment Video
Updated: Mar 30, 2026

A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
Cross-talk between PRMT1-mediated methylation and ubiquitylation on RBM15 controls RNA splicing
Li Zhang1, Ngoc-Tung Tran1, Hairui Su1
1Department of Biochemistry and Molecular Genetics, UAB Stem Cell Institute, The University of Alabama at Birmingham, Birmingham, United States.
Abstract:
RBM15, an RNA binding protein, determines cell-fate specification of many tissues including blood. We demonstrate that RBM15 is methylated by protein arginine methyltransferase 1 (PRMT1) at residue R578, leading to its degradation via ubiquitylation by an E3 ligase (CNOT4). Overexpression of PRMT1 in acute megakaryocytic leukemia cell lines blocks megakaryocyte terminal differentiation by downregulation of RBM15 protein level. Restoring RBM15 protein level rescues megakaryocyte terminal differentiation blocked by PRMT1 overexpression. At the molecular level, RBM15 binds to pre-messenger RNA intronic regions of genes important for megakaryopoiesis such as GATA1, RUNX1, TAL1 and c-MPL. Furthermore, preferential binding of RBM15 to specific intronic regions recruits the splicing factor SF3B1 to the same sites for alternative splicing. Therefore, PRMT1 regulates alternative RNA splicing via reducing RBM15 protein concentration. Targeting PRMT1 may be a curative therapy to restore megakaryocyte differentiation for acute megakaryocytic leukemia.
Insights
Protein arginine methyltransferase 1 (PRMT1) targets RBM15 for degradation, blocking blood cell differentiation. Targeting PRMT1 may restore megakaryocyte differentiation in acute megakaryocytic leukemia.
Area of Science:
- Molecular Biology
- Cell Biology
- Hematology
Background:
- RBM15 (RNA binding motif protein 15) is crucial for cell-fate specification, particularly in blood development.
- Aberrant megakaryocyte differentiation is a hallmark of acute megakaryocytic leukemia (AMKL).
Purpose of the Study:
- To investigate the regulatory mechanism of RBM15 by protein arginine methyltransferase 1 (PRMT1).
- To elucidate the role of PRMT1-mediated RBM15 regulation in megakaryocyte differentiation and AMKL.
Main Methods:
- Demonstrated RBM15 methylation by PRMT1 at R578, leading to ubiquitylation and degradation by CNOT4.
- Utilized AMKL cell lines to assess the impact of PRMT1 overexpression on RBM15 levels and megakaryocyte differentiation.
- Investigated RBM15's molecular function through RNA-binding assays and analysis of its interaction with splicing factors.
Main Results:
- PRMT1 overexpression in AMKL cells decreased RBM15 protein levels, inhibiting terminal differentiation.
- Restoring RBM15 levels rescued megakaryocyte differentiation.
- RBM15 binds intronic regions of key megakaryopoiesis genes (GATA1, RUNX1, TAL1, c-MPL) and recruits SF3B1 for alternative splicing.
Conclusions:
- PRMT1 negatively regulates RBM15 protein levels, thereby controlling alternative RNA splicing and megakaryocyte differentiation.
- Targeting PRMT1 presents a potential therapeutic strategy for restoring megakaryocyte differentiation in AMKL.
Related Concept Videos
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Regulation of Expression at Multiple Steps
RNA Stability
RNA Stability
RNA Splicing
RNA Splicing

